EVENT FREE SURVIVAL AT 12 MONTHS AND 24 MONTHS AS PREDICTORS FOR OUTCOME OF SYSTEMIC PERIPHERAL T CELL LYMPHOMA: ANALYSIS OF NATIONWIDE THAI LYMPHOMA STUDY GROUP
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.88_2630
Abstract: ysis of Tfh markers, many kinds of Tfh markers in PTCL with Tfhphenotype are less observed than AITL and more than PTCL, NOS. Among clinicopathological features of PTCL with Tfh-phenotype, cases with PS≥2 (P =… read more here.
Keywords: lymphoma; months predictors; months months; survival months ... See more keywords
Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-022-05741-9
Abstract: Prostate-specific-membrane-antigen/positron emission tomography (PSMA-PET) detects with high accuracy disease-recurrence, leading to changes in the management of biochemically-recurrent (BCR) prostate cancer (PCa). However, data regarding the oncological outcomes of patients who performed PSMA-PET are needed. The… read more here.
Keywords: event free; psma pet; therapy; psma ... See more keywords
Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy
Sign Up to like & getrecommendations! Published in 2020 at "European Radiology"
DOI: 10.1007/s00330-020-06815-8
Abstract: To explore the prognostic value of positron emission tomography (PET) radiomic features in the field of diffuse large B cell lymphoma (DLBCL) treated with a first-line immunochemotherapy. One-hundred thirty-two patients newly diagnosed with DLBCL were… read more here.
Keywords: year; fdg pet; free survival; year event ... See more keywords
Factors associated with event-free survival in Chinese patients with Takayasu’s arteritis
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Rheumatology"
DOI: 10.1007/s10067-020-05481-x
Abstract: To investigate long-term outcomes of Takayasu’s arteritis (TA) and explore the predictive factors associated with poor prognosis. We performed a retrospective study on consecutive TA patients admitted to the Nanjing Drum Tower Hospital during the… read more here.
Keywords: low dose; adverse outcomes; free survival; factors associated ... See more keywords
Meta-analysis of re-do stenting versus endarterectomy for in-stent stenosis following carotid artery stenting.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of vascular surgery"
DOI: 10.1016/j.jvs.2020.07.102
Abstract: OBJECTIVE In-stent restenosis (ISR) hinders the long-term patency of carotid artery stenting (CAS), yet no optimal treatment has been established. This study was aimed to compare outcomes of re-do CAS (rCAS) and carotid endarterectomy (CEA)… read more here.
Keywords: artery stenting; carotid artery; event free; rcas cea ... See more keywords
P5257Prediction of 12-month cardiovascular event-free survival with regadenoson perfusion cardiovascular magnetic resonance
Sign Up to like & getrecommendations! Published in 2019 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehz746.0228
Abstract: To identify and stratify coronary artery disease (CAD) non-invasively, cardiovascular magnetic resonance (CMR) derived perfusion imaging holds a class Ia recommendation. As Gold standard, hyperemia is induced by an intravenous application of adenosine in a… read more here.
Keywords: perfusion; cmr; regadenoson perfusion; event free ... See more keywords
Outcomes of a cardiac screening program: are those referred worse off?
Sign Up to like & getrecommendations! Published in 2023 at "European Journal of Preventive Cardiology"
DOI: 10.1093/eurjpc/zwad125.090
Abstract: Type of funding sources: Other. Main funding source(s): 1. Cardiovascular PHD Scholarship awarded by Research, Innovation and Development Trust Malta (supported by Beating Hearts Malta). 2. Tertiary Education Scholarship Scheme. Awareness of sudden cardiac death… read more here.
Keywords: screening program; event; group; event free ... See more keywords
Factors influencing outcomes in patients with Eisenmenger syndrome: a nine-year follow-up study
Sign Up to like & getrecommendations! Published in 2017 at "Pulmonary Circulation"
DOI: 10.1177/2045893217721928
Abstract: In patients with Eisenmenger syndrome, life expectancy is usually longer than in patients with other forms of pulmonary arterial hypertension (PAH). We conducted a cohort study in which patients were followed over a long period… read more here.
Keywords: patients eisenmenger; eisenmenger syndrome; study; event free ... See more keywords
Effects of apixaban compared with warfarin as gain in event-free time – a novel assessment of the results of the ARISTOTLE trial
Sign Up to like & getrecommendations! Published in 2019 at "European Journal of Preventive Cardiology"
DOI: 10.1177/2047487319886959
Abstract: Background A novel approach to determine the effect of a treatment is to calculate the delay of event, which estimates the gain of event-free time. The aim of this study was to estimate gains in… read more here.
Keywords: free time; trial; event free; event ... See more keywords
Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France
Sign Up to like & getrecommendations! Published in 2019 at "Haematologica"
DOI: 10.3324/haematol.2018.213207
Abstract: Allogeneic stem cell transplantation remains the only curative treatment for sickle cell anemia (SCA), but the place of myeloablative conditioning in the procedure remains to be defined. The aim of the present study was to… read more here.
Keywords: conditioning; free survival; transplantation; event free ... See more keywords
Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.835389
Abstract: Background Gastric cancer (GC) is one of the most common malignant cancers worldwide. The development of potential antitumor agents is being investigated and stimulates more clinical trials. Overall survival (OS) is consistently considered the primary… read more here.
Keywords: free survival; endpoint; event free; clinical trials ... See more keywords